Giovanni Latella

39PUBLICATIONS
76CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)BiomaterialsNutrigenomics and personalised nutritionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Apr 13, 2026
Correction: Ciafarone et al. Multi-Strain Probiotic Lysate Attenuates TGF-β1-Induced Intestinal Fibrosis and EMT Modulating Smad, Akt, and WNT/β-Catenin Pathways. Cells 2025, 14, 1432.

Alessia Ciafarone, Serena Artone, Valeria Ciummo

|Mar 28, 2026
Correction: Vernia et al. Immunoglobulin G4-Related Disease of the Intestine: A Clinicopathological Entity to Be Considered. Medicina 2024, 60, 57.

Filippo Vernia, Laura Cirella, Giuseppe Calvisi

|Sep 26, 2025
Multi-Strain Probiotic Lysate Attenuates TGF-β1-Induced Intestinal Fibrosis and EMT Modulating Smad, Akt, and WNT/β-Catenin Pathways.

Alessia Ciafarone, Serena Artone, Valeria Ciummo

|Aug 28, 2025
The Relationship Between Nutritional Status, Micronutrient Deficiency, and Disease Activity in IBD Patients: A Multicenter Cross-Sectional Study.

Marco Valvano, Susanna Faenza, Fabio Cortellini

|May 23, 2025
Inflammatory Bowel Disease in the Post-STRIDE II Era: Epidemiology and Long-Term Clinical Outcomes from a Population-Based Study.

|May 20, 2025
The angiotensin receptor blocker, losartan, reduces inflammation and fibrosis, and prevents relapse of fibrosis after steroid-induced remission, in mice prone to Crohn's disease-like ileitis.

Serena Artone, Shuvra Ray, Joseph J Williams

Pageof 7

Frequent Collaborators

20 joint publications

Angelo Viscido

12 joint publications

Filippo Vernia

11 joint publications

Marco Valvano

7 joint publications

Salvatore Longo